O
DHR icon

OrbiMed’s Danaher DHR Stock Holding History

OrbiMed’s Portfolio DHR Stock Details DHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$50.4M Sell
265,800
-34,000
-11% -$7.24M 1% 33
2025
Q4 		$68.6M Buy
299,800
+36,700
+14% +$8.07M 1.4% 21
2025
Q3 		$52.2M Buy
+263,100
New +$52.4M 1.23% 28
2020
Q1 		– Sell
-720,679
Closed -$98.1M – 148
2019
Q4 		$98.1M Buy
+720,679
New +$91.1M 1.4% 26

Other funds holding DHR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

OrbiMed's DHR Position: Q1 2026 in Review

OrbiMed reduced its Danaher (DHR) stake by 11% in Q1 2026, selling an estimated $7.24M and leaving 265,800 shares worth $50.4M. The position accounts for 1% of the portfolio, ranked #33.

OrbiMed first reported a position in DHR in Q4 2019 and has held it in 4 quarters since. The position peaked at $98.1M in Q4 2019. 2,166 funds tracked by Wall St. Rank hold DHR as of Q1 2026.

  • OrbiMed held 265,800 shares of Danaher worth $50.4M as of Q1 2026.
  • OrbiMed sold 34,000 Danaher shares in Q1 2026, an estimated $7.24M.
  • Danaher made up 1% of OrbiMed's portfolio in Q1 2026, its #33 holding.
  • OrbiMed first reported a position in Danaher in Q4 2019 and has held it in 4 quarters since.
  • OrbiMed's Danaher position peaked at $98.1M in Q4 2019.
  • 2,166 funds tracked by Wall St. Rank held Danaher as of Q1 2026.

Based on OrbiMed's 13F filing for Q1 2026, filed 15 May 2026.